Smith Julie
CIK 0001557928
Director
Filings
13
Latest May 29, 2026
Issuers covered
2
Showing
13 of 13
Page 1
Track record
6 of 6 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 83% | +4.0% | +5.5% | +7.2% | -3.4% |
| 90 days | 6 | 0% | -13.5% | -11.4% | -9.4% | -26.5% |
| 180 days | 3 | 33% | -21.9% | -1.8% | +0.5% | -64.2% |
| 365 days | 3 | 0% | -43.7% | -17.0% | -6.0% | -108.0% |
Issuers
Companies where Smith Julie has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| EXEL | Exelixis, Inc. | 9 | May 29, 2026 |
| STOK | Stoke Therapeutics, Inc. | 4 | Jun 4, 2025 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|